Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Comment by NSX001on May 09, 2022 2:44pm
111 Views
Post# 34667952

RE:RE:RE:RE:Web site

RE:RE:RE:RE:Web siteHi Golddetector,

I noticed that even after refreshing each time I changed the request for the "New Drug Submission" coloums, Tetra's standing in the Q are in different locations because of them being alphabetical. For example.

In the "Medicinal Ingredients Coloumn" standing, we are at 54th spot,
In the "Theraputic Area Coloumn", we are at 6th spot,
in the "Year, Month Submission Coloumn", we are at 19th spot,
In the "Company Name Coloumn", we are at 66th spot and,
In the "Submission Class Coloumn", we are at 7th spot.

We really have no idea where we are in the Q for completing the review and getting a DIN number.
I hope you or someone else can prove me wrong on this. Maybe the company has a better idea where they stand in line, it would be really nice to to know.

NSX001
<< Previous
Bullboard Posts
Next >>